HOME >> BIOLOGY >> NEWS
Fighting Wheat Scab In New York State

ITHACA, N.Y. -- Fusarium head blight, a plant disease also known as wheat scab, has taken aim at America's breadbasket and threatens New York's $30 million wheat-growing industry, according to Cornell University plant pathologists. The scientists will be speaking at the American Phytopathological Society's annual meeting, Aug. 9-13, in Rochester, N.Y.

"Wheat is an important crop in New York state. As in most of the Midwestern states, epidemics of scab disease threaten New York's wheat industry," said Gary Bergstrom, Cornell professor of plant pathology.

In New York, winter wheat is grown on 120,000 to 150,000 acres annually, primarily in the western and central parts of the state, he said. The wheat grain, with a New York grower cash receipt value of approximately $30 million annually, also is milled and processed by several New York food companies into flour for crackers and other pastry products for human consumption.

But, the scab is increasing as a threat to sustainable wheat production. In 1996, New York wheat farmers lost more than $12 million due to the widespread occurrence of scab, Bergstrom said. "All of our adapted pastry wheat varieties are susceptible to scab, which is most severe when wet weather occurs while the crop flowers in late May-early June," he said.

Fortunately, wet weather was not encountered during wheat flowering this year in New York, and preliminary estimates call for excellent yields of New York winter wheat in 1997.

In the Midwest -- North Dakota, South Dakota and Minnesota -- yield and grain quality losses amounted to nearly $1 billion in 1993 and ranged from $200 million to $400 million annually since then. In Ohio, Michigan, Indiana and Illinois, losses from wheat scab exceeded $300 million in 1995 and 1996. Food safety is also an issue with the scab, as products made from the infected grain could be contaminated by a mold by-product, a poison known as vomitoxin.

Cornell researchers are collaborating wi
'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
29-Jul-1997


Page: 1 2 3

Related biology news :

1. Fighting Mycobacterium tuberculosis with structural proteomics
2. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
3. Fighting the spread of sudden oak death
4. Fighting the battle of the bulge in children
5. Fighting breast cancer at the molecular level
6. Fighting Fungi
7. Fighting skin cancers with computers and technology
8. Fighting diabetes: UD researchers move closer to chip-based control of smart, implantable insulin pumps
9. Trash From Crop-Processing Plant Harvested For Disease-Fighting Agents
10. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
11. Chemical Contaminants May Inhibit Cancer-Fighting White Blood Cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fighting Wheat Scab New York State

(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... NextCODE, which provides comprehensive capabilities for using the genome to ... on their publication of the largest studies of whole-genome data ... online in Nature Genetics – are ... sequence variation, authored by a team of deCODE scientists led ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: